The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3-fluoro-4-hydroxypyridin-2-one ID: ALA444707
Max Phase: Preclinical
Molecular Formula: C10H12FNO6
Molecular Weight: 261.20
Molecule Type: Small molecule
Associated Items:
Representations Canonical SMILES: O=c1c(F)c(O)ccn1[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C10H12FNO6/c11-6-4(14)1-2-12(9(6)17)10-8(16)7(15)5(3-13)18-10/h1-2,5,7-8,10,13-16H,3H2/t5-,7-,8+,10-/m1/s1
Standard InChI Key: BKFGOEDDMLZXNF-PJGXCUNHSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 261.20Molecular Weight (Monoisotopic): 261.0649AlogP: -1.70#Rotatable Bonds: 2Polar Surface Area: 112.15Molecular Species: NEUTRALHBA: 7HBD: 4#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): 0CX Acidic pKa: 8.48CX Basic pKa: CX LogP: -1.74CX LogD: -1.78Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.50Np Likeness Score: 1.17
References 1. Robins MJ, Yang H, Miranda K, Peterson MA, De Clercq E, Balzarini J.. (2009) Synthesis and biological evaluation of 3,3-difluoropyridine-2,4(1H,3H)-dione and 3-deaza-3-fluorouracil base and nucleoside derivatives., 52 (9): [PMID:19378989 ] [10.1021/jm900203h ]
